Literature DB >> 8748710

A model of the active site of dipeptidyl peptidase IV predicted by comparative molecular field analysis and molecular modelling simulations.

W Brandt1, T Lehmann, I Thondorf, I Born, M Schutkowski, J U Rahfeld, K Neubert, A Barth.   

Abstract

A molecular model of the active site of the serine protease dipeptidyl peptidase IV (DPP IV or CD26) has been developed on the basis of comparative molecular field analysis (CoMFA) of competitive inhibitors and by force field calculations. By application of CoMFA experimentally obtained inhibition constants Ki have been successfully predicted. The resulting steric and electrostatic coefficients of CoMFA were used for the development of the molecular model. The main assumptions of the model are the recognition of substrates or inhibitors by the side chains of a tyrosine (S1-position) and a tryptophan residue (S2-position). The model helps us to understand a multitude of experimental data regarding the substrate specificity of this enzyme as well as results obtained by genetic engineering experiments by other authors. General conclusions concerning a new family of serine proteases are drawn and discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748710     DOI: 10.1111/j.1399-3011.1995.tb01605.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  5 in total

1.  3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.

Authors:  Raghuvir R S Pissurlenkar; Mushtaque S Shaikh; Evans C Coutinho
Journal:  J Mol Model       Date:  2007-08-04       Impact factor: 1.810

2.  Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.

Authors:  P Ruiz; N Zacharievich; M Shenkin
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV.

Authors:  A Banbula; M Bugno; J Goldstein; J Yen; D Nelson; J Travis; J Potempa
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.

Authors:  Sahana D Rao; Qifeng Chen; Qinghui Wang; Elizabeth L Orth-He; Michelle Saoi; Andrew R Griswold; Abir Bhattacharjee; Daniel P Ball; Hsin-Che Huang; Ashley J Chui; Dominic J Covelli; Shaochen You; Justin R Cross; Daniel A Bachovchin
Journal:  Nat Chem Biol       Date:  2022-02-14       Impact factor: 16.174

5.  Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.

Authors:  Yan-Ke Jiang
Journal:  J Mol Model       Date:  2010-01-13       Impact factor: 1.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.